Bluejay Diagnostics, Inc.
BJDX
$4.00
-$0.03-0.74%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.43% | 12.10% | 0.82% | -7.06% | -19.90% |
| Total Depreciation and Amortization | -72.54% | -28.60% | 69.36% | 154.86% | 186.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 154.43% | -15.09% | -101.98% | -71.32% | -60.77% |
| Change in Net Operating Assets | -395.65% | -57.55% | 1,126.50% | 15.23% | 1,070.77% |
| Cash from Operations | -4.46% | 6.55% | 12.75% | -7.39% | -15.85% |
| Capital Expenditure | 53.95% | 70.23% | 73.29% | 41.28% | 12.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 53.95% | 70.23% | 73.29% | 41.28% | 12.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -52,000.00% | -59,962.50% | -320.00% | -500.00% | -- |
| Issuance of Common Stock | 645.18% | 47,166.09% | 17,515.22% | 5,404.50% | -91.41% |
| Repurchase of Common Stock | -- | 100.00% | 97.40% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -325.88% | -11,198.50% | -5,531.50% | -1,976.50% | -210.17% |
| Cash from Financing | 784.56% | 21,594.57% | 7,899.80% | 13,622.22% | -94.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.27% | 128.88% | 60.16% | 11.49% | -174.94% |
